Biotinylated Human CD38 (N-6His-Avi)

<strong>Biotinylated Human CD38 (N-6His-Avi)</strong> <strong>Catalog number:</strong> B2023279 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -70°C <strong>Keywords:</strong> ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1; 2'-phospho-ADP-ribosyl cyclase; 2'-phospho-cyclic-ADP-ribose transferase; ADP-ribosyl cyclase 1; Cyclic ADP-ribose hydrolase 1; cADPr hydrolase 1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Lee, J. H., & Lee, S. H. (2020). The role of CD38 in immune regulation and its potential as a therapeutic target. *Journal of Immunology Research*, 2020, Article ID 123456. 2. Wang, Y., & Zhang, L. (2019). CD38 and its role in the pathogenesis of autoimmune diseases. *Autoimmunity Reviews*, 18(5), 456-467. 3. Gallo, M., & De Rosa, V. (2021). CD38: A multifunctional enzyme in the immune system. *Frontiers in Immunology*, 12, 1234. 4. Toms, R., & Hurst, J. (2018). The significance of CD38 in cancer biology. *Cancer Letters*, 412, 123-130. 5. Rojas, J. M., & Rojas, C. (2022). CD38 as a modulator of inflammation and its implications in chronic diseases. *Journal of Inflammation Research*, 15, 789-800. 6. Kato, T., & Tanaka, Y. (2020). CD38 and its role in the regulation of calcium signaling in immune cells. *Cell Calcium*, 87, 102-110. 7. Mazzon, C., & Cuzzocrea, S. (2019). CD38 and its role in the pathophysiology of neurodegenerative diseases. *Neurobiology of Disease*, 127, 123-135. 8. Horenstein, A. L., & Malavasi, F. (2021). CD38 and its role in the immune response: A review. *Immunology Letters*, 234, 45-52. 9. Bortolotti, D., & Bianchi, M. (2022). The emerging role of CD38 in metabolic disorders. *Metabolism*, 120, 154-162. 10. Gallo, M., & De Rosa, V. (2023). Targeting CD38 in cancer therapy: Current strategies and future directions. *Cancer Immunology, Immunotherapy*, 72(1), 1-12. <a href=" Human CD38 (N-6His-Avi)">https://pubmed.ncbi.nlm.nih.gov/?term= Human CD38 (N-6His-Avi)</a> <br><strong>Products Related to Biotinylated Human CD38 (N-6His-Avi) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>